Your browser doesn't support javascript.
Persistent somatic symptoms are key to individual illness perception at one year after COVID-19 in a cross-sectional analysis of a prospective cohort study.
Hüfner, Katharina; Tymoszuk, Piotr; Sahanic, Sabina; Luger, Anna; Boehm, Anna; Pizzini, Alex; Schwabl, Christoph; Koppelstätter, Sabine; Kurz, Katharina; Asshoff, Malte; Mosheimer-Feistritzer, Birgit; Pfeifer, Bernhard; Rass, Verena; Schroll, Andrea; Iglseder, Sarah; Egger, Alexander; Wöll, Ewald; Weiss, Günter; Helbok, Raimund; Widmann, Gerlig; Sonnweber, Thomas; Tancevski, Ivan; Sperner-Unterweger, Barbara; Löffler-Ragg, Judith.
  • Hüfner K; Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital for Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.
  • Tymoszuk P; Data Analytics As a Service Tirol, Innsbruck, Austria.
  • Sahanic S; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
  • Luger A; Department of Radiology, Medical University of Innsbruck, Innsbruck, Austria.
  • Boehm A; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
  • Pizzini A; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
  • Schwabl C; Department of Radiology, Medical University of Innsbruck, Innsbruck, Austria.
  • Koppelstätter S; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
  • Kurz K; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
  • Asshoff M; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
  • Mosheimer-Feistritzer B; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
  • Pfeifer B; Division for Health Networking and Telehealth, Biomedical Informatics and Mechatronics, UMIT, Hall in Tyrol, Austria.
  • Rass V; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
  • Schroll A; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
  • Iglseder S; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
  • Egger A; Central Institute of Medical and Chemical Laboratory Diagnostics, University Hospital Innsbruck, Innsbruck, Austria.
  • Wöll E; Department of Internal Medicine, St. Vinzenz Hospital, Zams, Austria.
  • Weiss G; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
  • Helbok R; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
  • Widmann G; Department of Radiology, Medical University of Innsbruck, Innsbruck, Austria.
  • Sonnweber T; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
  • Tancevski I; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
  • Sperner-Unterweger B; Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital for Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.
  • Löffler-Ragg J; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria. Electronic address: judith.loeffler@i-med.ac.at.
J Psychosom Res ; 169: 111234, 2023 Jun.
Article in English | MEDLINE | ID: covidwho-2263526
ABSTRACT

OBJECTIVE:

Subjective illness perception (IP) can differ from physician's clinical assessment results. Herein, we explored patient's IP during coronavirus disease 2019 (COVID-19) recovery.

METHODS:

Participants of the prospective observation CovILD study (ClinicalTrials.gov NCT04416100) with persistent somatic symptoms or cardiopulmonary findings one year after COVID-19 were analyzed (n = 74). Explanatory variables included demographic and comorbidity, COVID-19 course and one-year follow-up data of persistent somatic symptoms, physical performance, lung function testing, chest computed tomography and trans-thoracic echocardiography. Factors affecting IP (Brief Illness Perception Questionnaire) one year after COVID-19 were identified by regularized modeling and unsupervised clustering.

RESULTS:

In modeling, 33% of overall IP variance (R2) was attributed to fatigue intensity, reduced physical performance and persistent somatic symptom count. Overall IP was largely independent of lung and heart findings revealed by imaging and function testing. In clustering, persistent somatic symptom count (Kruskal-Wallis test η2 = 0.31, p < .001), fatigue (η2 = 0.34, p < .001), diminished physical performance (χ2 test, Cramer V effect size statistic V = 0.51, p < .001), dyspnea (V = 0.37, p = .006), hair loss (V = 0.57, p < .001) and sleep problems (V = 0.36, p = .008) were strongly associated with the concern, emotional representation, complaints, disease timeline and consequences IP dimensions.

CONCLUSION:

Persistent somatic symptoms rather than abnormalities in cardiopulmonary testing influence IP one year after COVID-19. Modifying IP represents a promising innovative approach to treatment of post-COVID-19 condition. Besides COVID-19 severity, individual IP should guide rehabilitation and psychological therapy decisions.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Medically Unexplained Symptoms / COVID-19 Type of study: Cohort study / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Journal: J Psychosom Res Year: 2023 Document Type: Article Affiliation country: J.jpsychores.2023.111234

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Medically Unexplained Symptoms / COVID-19 Type of study: Cohort study / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Journal: J Psychosom Res Year: 2023 Document Type: Article Affiliation country: J.jpsychores.2023.111234